Pulse Biosciences, Inc.PLSENASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank41
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P41
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-13.43%
Q3 2025-1.48%
Q2 20254.84%
Q1 2025-47.50%
Q4 2024-1.49%
Q3 2024-7.57%
Q2 202413.91%
Q1 2024-43.50%
Q4 202335.12%
Q3 2023-14.02%
Q2 2023-39.48%
Q1 202317.45%
Q4 202225.14%
Q3 202216.72%
Q2 202219.10%
Q1 2022-23.74%
Q4 20215.03%
Q3 202117.95%
Q2 2021-40.24%
Q1 2021-23.12%
Q4 2020-10.72%
Q3 2020-9.44%
Q2 202019.66%
Q1 2020-6.92%
Q4 2019-7.78%
Q3 201912.94%
Q2 2019-32.35%
Q1 2019-16.31%
Q4 20188.39%
Q3 2018-18.18%
Q2 2018-15.93%
Q1 2018-23.01%
Q4 2017-22.23%
Q3 20178.50%
Q2 2017-46.94%
Q1 2017-10.87%
Q4 2016-13.55%
Q3 201614.11%
Q2 2016-53.96%
Q1 2016-11.78%